Detalles de la búsqueda
1.
Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Lancet Oncol
; 20(10): 1420-1431, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471158
2.
Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.
Lancet Oncol
; 20(12): 1710-1718, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31606419
3.
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(2): 362-368, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287390
4.
Fertility counseling before cancer treatment and subsequent reproductive concerns among female adolescent and young adult cancer survivors.
Cancer
; 125(6): 980-989, 2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30489638
5.
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Biol Blood Marrow Transplant
; 24(7): 1313-1321, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653206
6.
Iron Overload in Survivors of Childhood Cancer.
J Pediatr Hematol Oncol
; 40(5): 396-400, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28562518
7.
Utility of Echocardiography as Screening for Late-onset Anthracycline-induced Cardiotoxicity in Pediatric Cancer Survivors: Observations from the First Decade After End of Therapy.
J Pediatr Hematol Oncol
; 40(5): e283-e288, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29432303
8.
The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies.
Biol Blood Marrow Transplant
; 23(1): 24-29, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27737772
9.
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 23(5): 726-735, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28115275
10.
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(4): 552-561, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28065838
11.
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Biol Blood Marrow Transplant
; 23(3): 379-387, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28068510
12.
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Biol Blood Marrow Transplant
; 23(8): 1229-1240, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28479164
13.
Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
Biol Blood Marrow Transplant
; 23(9): 1422-1428, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28533057
14.
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.
Biol Blood Marrow Transplant
; 23(8): 1327-1334, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28461213
15.
Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
Cancer
; 122(23): 3687-3696, 2016 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27504874
16.
Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.
Curr Opin Pediatr
; 28(1): 3-11, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26626557
17.
Conditional survival in pediatric malignancies: analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program.
Cancer
; 121(7): 1108-17, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25557134
18.
Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response.
Br J Haematol
; 166(2): 209-12, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24661075
19.
Pulmonary outcomes in survivors of childhood central nervous system malignancies: a report from the Childhood Cancer Survivor Study.
Pediatr Blood Cancer
; 61(2): 319-25, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24127436
20.
Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
EClinicalMedicine
; 69: 102487, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38420219